Delhi: HC notice to Malvinder Singh, Sunil Godhwani on ED's plea

Published On 2019-11-26 08:11 GMT   |   Update On 2019-11-26 08:11 GMT
Advertisement

New Delhi: The Delhi High Court on Monday issued notice to Fortis Healthcare promoter Malvinder Singh and former CMD of Religare Enterprises Limited Sunil Godhwani on a plea by Enforcement Directorate seeking their custody till November 28 in a case related to alleged misappropriation of funds at Religare Finvest Limited (RFL).

Singh and Godhwani were sent to the judicial custody by the trial court on Saturday which was challenged by the Enforcements Directorate in the High Court today.

Advertisement

After hearing the argument, Justice Chandershekhar sought the reply of both businessmen and fixed the matter for hearing tomorrow.

Enforcement Directorate counsel, Advocate Amit Mahajan and Advocate Nitesh Rana argued that we need confrontation of them with some people, we are trying to trace a fund - public money which is siphoned off by them.

The ED is seeking more days custody and set aside of trial court order.

Read Also: Ex-Fortis Promoter Malvinder Singh, Former Religare Executive Godhwani Sent To Judicial Custody

Special Judge Sandeep Yadav of Saket Court on Saturday refused to grant more custody to ED and sent both the accused to Tihar Jail till December 7 after they were produced before court on expiry of their custodial interrogation. The court had dismissed the application saying "further custodial interrogation is neither required nor warranted."

The agency had taken both into custody on November 14. Singh and Godhwani have been accused of laundering money, punishable under Sections 3 and 4 of the Prevention of Money Laundering Act.

Read Also: Malvinder Accusing Shivinder of Fraud: Delhi District Court seeks Action Taken Report from Police

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News